A large number of studies have shown that the activation of NRLP3 inflammasome affects the interaction of glucose tolerance, insulin sensitivity and intestinal microorganisms, leading to the occurrence and development of T2DM (205–207). The gene discussed is INS; the disease is type 2 diabetes mellitus.